Donate
Category 2

Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer:

Mehmet Salih İyikesici , Abdul Kadir Slocum , Ayshe Slocum , Ferhan Bulent Berkarda , Miriam Kalamian , Thomas N. Seyfried
Category 2
09/11/2025

Topics

Introduction

Triple-negative breast cancer (TNBC) is more aggressive and metastatic than other breastTriple-negative breast cancer (TNBC) is more aggressive and metastatic than other breastcancer types. Cytotoxic chemotherapy is presently the predominant systemic therapy for TNBCpatients. This case report highlights the influence of metabolically supported chemotherapy(MSCT), ketogenic diet (KD), hyperthermia (HT), and hyperbaric oxygen therapy (HBOT) in anoverweight 29-year-old woman with stage IV (T4N3M1) triple-negative invasive ductalcarcinoma of the breast. The patient presented with an observable mass in her left breastdetected during a physical examination in December 2015.

Read More

Back to Publications

Other Publications of Interest

Category 3

Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma:

Temozolomide (TMZ) is part of the standard of care for treatingIntroduction: Temozolomide (TMZ) is part of the standard of care

Read More
Category 4

Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Introduction No major advances have been made in improving overall survival for glioblastoma (GBM) in almost 100 years. The currentNo

Read More
Category 4

Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma:

Introduction Glioblastoma (GBM) is an aggressive primary human brain tumour that has resisted effectiveGlioblastoma (GBM) is an aggressive primary human

Read More
Donate